Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine

Area of Science:

• Neuroscience
• Neurology
• Medical Imaging

Background:

• Medication overuse transforms episodic migraine into chronic daily headache through unknown mechanisms.
• Understanding the brain alterations in medication overuse headache (MOH) is crucial for developing targeted treatments.

Purpose of the Study:

• To identify candidate brain regions involved in the transformation of episodic migraine to chronic daily headache due to medication overuse.
• To investigate the metabolic changes associated with analgesic overuse in migraine patients.

Main Methods:

• Utilized 18-fluorodeoxyglucose Positron Emission Tomography (18-FDG PET) to measure glucose metabolism.
• Assessed 16 chronic migraineurs with analgesic overuse before and after 3 weeks of medication withdrawal.
• Compared metabolic data with a control group (n=68).

Main Results:

• Before withdrawal, chronic migraineurs exhibited hypometabolism in the bilateral thalamus, orbitofrontal cortex (OFC), anterior cingulate gyrus, insula/ventral striatum, and right inferior parietal lobule, with hypermetabolism in the cerebellar vermis.
• Following medication withdrawal, most metabolic abnormalities resolved, except for the OFC, which showed further decreased metabolism.
• Orbitofrontal hypometabolism was more pronounced in patients overusing combination analgesics or ergotamine-caffeine preparations.

Conclusions:

• Medication overuse headache is linked to reversible metabolic changes in pain processing areas, similar to other chronic pain conditions.
• Persistent orbitofrontal hypofunction, observed after withdrawal, may indicate a predisposition to recurrent analgesic overuse and drug dependence in some migraineurs.